Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company fizer (NYSE: PFE) and Wyeth (NYSE: WYE) on January 26 announced that they have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion. The Boards of Directors of both companies have approved the combination.
their a criminal bunch. worse than the mafia.
x11115 2 years ago
tell them to give me lifetime 7 mg ativan at night, then i'll be happy hahahaha
no anxiety attacks ever again, i'll just knock my self out every day
wiccamelissa 2 years ago
Wonder why they aren't bragging about the bail out money they got from the bail out banks to buy Wyeth. I mean Pfizer has been bragging about the 20,000 jobs they are going eliminate after the transaction is done. Just another company that is going into the toilet courtesy of Pfizer. Pfizer ... bunch of greedy pricks.
WTF10965 2 years ago